INTRODUCTION
Diffuse Neurofibroma is an uncommon, but distinct variant of Neurofibroma affecting the trunk, head and neck regions of adolescents and young adults. It is not clearly known how diffuse Neurofibromas are associated with Neurofibromatosis, although it has been suggested that 10% of cases of diffuse Neurofibromas have Von Recklinghausen's disease NF-1.
1, 2 We report a case of recurrent Diffuse Neurofibroma of the scalp in a 20 year old young adult male patient, which was confirmed by radiological imaging and characteristic histopathogical findings.
CASE REPORT
A 20 year old male patient was admitted under surgical speciality for recurrent scalp swelling. The initial age at presentation was when he was 2 years old. Surgery was attempted and tumour was removed when the patient was 10 years old. At present the patient came back with a history of recurrent scalp swelling, gradually increasing in size and has attained the present size since 2 years, i.e. when the patient was 18 years of age.
Physical examination revealed a 20 x15 cms, oval to oblong enplaque swelling over the scalp, soft in consistency, non-cystic, non-tender with no visible pulsations or bruit on auscultation over the swelling. The swelling was seen occupying left parieto-temporal regions of the scalp and extending on to the opposite side crossing the midline. The overlying skin was normal excepting for the old scar on the left lateral side of the scalp.
Radiographs of the skull did not reveal any bone erosion. CT scan of the head showed an extra cranial soft tissue mass on the left side of the scalp extending on to the right side with no intracranial extension. The underlying bone showed focal thickening. MRI of the brain with contrast on T1-weighted imaging revealed linear or reticular strands of intermediate signal intensity in the subcutaneous fat, indicating the tumour tissue along with collagen and ecstatic vessels, while on T2-weighted imaging were of high signal intensity, in contrast to collagen fibres. Fine needle aspiration cytology was done which revealed few mature adipocytes along with blood elements. A diagnosis of Lipoma was made. Excision biopsy was done with skin grafting and the specimen was submitted for histopathological examination.
Pathology
Received multiple grey white to grey brown soft tissue masses, largest and smallest masses measuring 11 x 8 x 1 cm and 1.5 x 1.5 x 1 cm in dimensions respectively. Cut section of the masses revealed grey white, glistening, homogenous appearance with spotty areas of haemorrhages. Multiple H & E stained sections studied revealed a tumour tissue arranged in whorls, fascicles admixed with proliferated blood vessels. Cells were fusiform, with elongated nuclei and surrounded by a uniform myxoid matrix of wire-like fine fibrillary collagen fibres and admixed with plenty of WagnerMeissner's bodies. 4 There was no evidence of any pleomorphism, necrosis, increased mitoses or bizarre tumour giant cells. A diagnosis of diffuse neurofibroma was made. IHC studies with S100 protein were strongly and diffusely positive, thus complementing the diagnosis. 5 Thorough examination of the patient for stigmata of Neurofibromatosis 1, revealed cafe-au-lait spots all over the body, especially over the nape of the neck, back and shoulder regions ranging in size from 0.3 to 1.5 cm in diameter. No lisch nodules were identified. 
DISCUSSION
Neurofibromas are benign tumours of the peripheral nerves of neuroectodermal origin. The essential cells in neurofibroma are of Schwann cell origin. Diffuse neurofibroma is an uncommon, but distinct form of neurofibroma, both clinically and histologically. It is variable in size, though often large. It is characterized by marked dermal and subcutaneous thickening that most often appears in the trunk or head & neck regions of young adults. Intracranial extension of the tumour has rarely been reported. 6 This lesion has also been termed as paraneurofibroma indicating its extension beyond the confines of the perineurium. 7 At least 10% of tumours are associated with NF-1, although Megahed reported that 61% of his 13 patients with diffuse neurofibromas had NF-1. The imaging procedures to diagnose Diffuse Neurofibromas include, Ultrasonography, CT-Scan & MRI. MRI is the investigative tool of choice for the diagnosis, because it better defines the anatomic relationship between neurofibroma and adjacent tissues, like muscles, vessels and neural structures. MRI differentiates diffuse neurofibroma from those of the localized and plexiform types of neurofibroma. On MRI, diffuse neurofibromas exhibit typical target pattern, revealing plaque-like infiltrating masses involving the skin and subcutaneous tissue characterized by the presence of linear or reticular strands. These strands are of hypointense signal intensity on T 1 weighted images and appear hyperintense on T 2 weighted images in comparison with muscle. Localized neurofibroma appears as a well-defined nodule while plexiform neurofibroma appears as a serpiginous lesion. The MRI findings of our patient correlated with all the above findings. On histopathology the tumour is ill defined, diffusely infiltrating the dermis and subcutaneous tissues. Despite its infiltrative nature, the tumour envelops the normal structures rather than infiltrate or destroy them. Cells are fusiform, with elongated nuclei and are surrounded by a myxoid matrix of wire-like collagen fibres. Wagner Meissner's bodies are characteristic, but may not be always present. Neurofibromas show immunoreactivity with S100 protein, a sensitive but not a specific marker for benign nerve sheath tumours. Although malignant transformation of neurofibromas has been reported in patients with NF1 it rarely occurs in diffuse neurofibromas. Pain or enlargement of a neurofibroma may herald the malignant transformation. In summary, we report a case of recurrent Diffuse Neurofibroma of the scalp in a young adult in the background of NF-1. This is a rare peripheral nerve sheath tumour with characteristic radiological appearances that correlates well with the distinct histopathology. The reticular appearance is due to a network of abnormal nerves set in a collagen background. It is known to be demonstrated accurately on MRI, particularly contrast enhanced T1-W & T2-W sequences. However confirmation is by the characteristic histopathology in conjunction with IHC correlation. The post-operative period of our case was uneventful and regular follow-up was advised.
